Angiotensin Receptor Blockers (ARBs) Market Report

Global and Region Angiotensin Receptor Blockers (ARBs) Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Jul 31, 2022
  • PAGES：221
  • REPORT CODE：GMM925841
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Angiotensin Receptor Blockers (ARBs) market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Angiotensin Receptor Blockers (ARBs)market, defines the market attractiveness level of Angiotensin Receptor Blockers (ARBs) market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Angiotensin Receptor Blockers (ARBs) industry, describes the types of Angiotensin Receptor Blockers (ARBs) market, the applications of major players and the market size, and deeply analyzes the current situation of the global Angiotensin Receptor Blockers (ARBs) market and the development prospects and opportunities of Angiotensin Receptor Blockers (ARBs) industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Angiotensin Receptor Blockers (ARBs) market in Chapter 13.

    By Player:

    • Bristol-Myers Squibb

    • Sanofi

    • Eli Lilly

    • Pfizer

    • Merck

    • Bayer

    • Jhonson and Johnson

    • Astra Zeneca

    • Novartis

    • GSK

    • Teva Pharmaceutical

    By Type:

    • Valsartan

    • Telmisartan

    • Losartan

    • Irbesartan

    • Azilsartan

    • Olmesartan

    By End-User:

    • Hypertension

    • Cardiovascular Diseases

    • Kidney Diseases

    • Other

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Angiotensin Receptor Blockers (ARBs) Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Angiotensin Receptor Blockers (ARBs) Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Angiotensin Receptor Blockers (ARBs) Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Angiotensin Receptor Blockers (ARBs) Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Angiotensin Receptor Blockers (ARBs) Market Analysis and Outlook to 2022

    • 7.1 Global Angiotensin Receptor Blockers (ARBs) Consumption (2017-2022)

    • 7.2 United States Angiotensin Receptor Blockers (ARBs) Consumption (2017-2022)

    • 7.3 Europe Angiotensin Receptor Blockers (ARBs) Consumption (2017-2022)

    • 7.4 China Angiotensin Receptor Blockers (ARBs) Consumption (2017-2022)

    • 7.5 Japan Angiotensin Receptor Blockers (ARBs) Consumption (2017-2022)

    • 7.6 India Angiotensin Receptor Blockers (ARBs) Consumption (2017-2022)

    • 7.7 South Korea Angiotensin Receptor Blockers (ARBs) Consumption (2017-2022)

    8 Region and Country-wise Angiotensin Receptor Blockers (ARBs) Market Analysis and Outlook to 2028

    • 8.1 Global Angiotensin Receptor Blockers (ARBs) Consumption Forecast (2022-2028)

    • 8.2 United States Angiotensin Receptor Blockers (ARBs) Consumption Forecast (2022-2028)

    • 8.3 Europe Angiotensin Receptor Blockers (ARBs) Consumption Forecast (2022-2028)

    • 8.4 China Angiotensin Receptor Blockers (ARBs) Consumption Forecast (2022-2028)

    • 8.5 Japan Angiotensin Receptor Blockers (ARBs) Consumption Forecast (2022-2028)

    • 8.6 India Angiotensin Receptor Blockers (ARBs) Consumption Forecast (2022-2028)

    • 8.7 South Korea Angiotensin Receptor Blockers (ARBs) Consumption Forecast (2022-2028)

    9 Global Angiotensin Receptor Blockers (ARBs) Market Outlook by Types and Applications to 2022

    • 9.1 Global Angiotensin Receptor Blockers (ARBs) Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Valsartan Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Telmisartan Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Losartan Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Irbesartan Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global Azilsartan Consumption and Growth Rate (2017-2022)

      • 9.1.6 Global Olmesartan Consumption and Growth Rate (2017-2022)

    • 9.2 Global Angiotensin Receptor Blockers (ARBs) Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hypertension Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Cardiovascular Diseases Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Kidney Diseases Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Other Consumption and Growth Rate (2017-2022)

    10 Global Angiotensin Receptor Blockers (ARBs) Market Outlook by Types and Applications to 2028

    • 10.1 Global Angiotensin Receptor Blockers (ARBs) Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Valsartan Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Telmisartan Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Losartan Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global Irbesartan Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.5 Global Azilsartan Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.6 Global Olmesartan Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Angiotensin Receptor Blockers (ARBs) Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Hypertension Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Cardiovascular Diseases Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Kidney Diseases Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.4 Global Other Consumption Forecast and Growth Rate (2022-2028)

    11 Global Angiotensin Receptor Blockers (ARBs) Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Angiotensin Receptor Blockers (ARBs) Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Angiotensin Receptor Blockers (ARBs) Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Angiotensin Receptor Blockers (ARBs) Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Angiotensin Receptor Blockers (ARBs) Market Competitive Analysis

    • 14.1 Bristol-Myers Squibb

      • 14.1.1 Bristol-Myers Squibb Company Details

      • 14.1.2 Bristol-Myers Squibb Angiotensin Receptor Blockers (ARBs) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Bristol-Myers Squibb Angiotensin Receptor Blockers (ARBs) Product and Service

    • 14.2 Sanofi

      • 14.2.1 Sanofi Company Details

      • 14.2.2 Sanofi Angiotensin Receptor Blockers (ARBs) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Sanofi Angiotensin Receptor Blockers (ARBs) Product and Service

    • 14.3 Eli Lilly

      • 14.3.1 Eli Lilly Company Details

      • 14.3.2 Eli Lilly Angiotensin Receptor Blockers (ARBs) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Eli Lilly Angiotensin Receptor Blockers (ARBs) Product and Service

    • 14.4 Pfizer

      • 14.4.1 Pfizer Company Details

      • 14.4.2 Pfizer Angiotensin Receptor Blockers (ARBs) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Pfizer Angiotensin Receptor Blockers (ARBs) Product and Service

    • 14.5 Merck

      • 14.5.1 Merck Company Details

      • 14.5.2 Merck Angiotensin Receptor Blockers (ARBs) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Merck Angiotensin Receptor Blockers (ARBs) Product and Service

    • 14.6 Bayer

      • 14.6.1 Bayer Company Details

      • 14.6.2 Bayer Angiotensin Receptor Blockers (ARBs) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Bayer Angiotensin Receptor Blockers (ARBs) Product and Service

    • 14.7 Jhonson and Johnson

      • 14.7.1 Jhonson and Johnson Company Details

      • 14.7.2 Jhonson and Johnson Angiotensin Receptor Blockers (ARBs) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Jhonson and Johnson Angiotensin Receptor Blockers (ARBs) Product and Service

    • 14.8 Astra Zeneca

      • 14.8.1 Astra Zeneca Company Details

      • 14.8.2 Astra Zeneca Angiotensin Receptor Blockers (ARBs) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Astra Zeneca Angiotensin Receptor Blockers (ARBs) Product and Service

    • 14.9 Novartis

      • 14.9.1 Novartis Company Details

      • 14.9.2 Novartis Angiotensin Receptor Blockers (ARBs) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Novartis Angiotensin Receptor Blockers (ARBs) Product and Service

    • 14.10 GSK

      • 14.10.1 GSK Company Details

      • 14.10.2 GSK Angiotensin Receptor Blockers (ARBs) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 GSK Angiotensin Receptor Blockers (ARBs) Product and Service

    • 14.11 Teva Pharmaceutical

      • 14.11.1 Teva Pharmaceutical Company Details

      • 14.11.2 Teva Pharmaceutical Angiotensin Receptor Blockers (ARBs) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 Teva Pharmaceutical Angiotensin Receptor Blockers (ARBs) Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Angiotensin Receptor Blockers (ARBs)

    • Figure Angiotensin Receptor Blockers (ARBs) Picture

    • Table Global Angiotensin Receptor Blockers (ARBs) Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Angiotensin Receptor Blockers (ARBs) Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Angiotensin Receptor Blockers (ARBs) Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Angiotensin Receptor Blockers (ARBs) Consumption by Country (2017-2022)

    • Figure United States Angiotensin Receptor Blockers (ARBs) Consumption and Growth Rate (2017-2022)

    • Table Europe Angiotensin Receptor Blockers (ARBs) Consumption and Growth Rate (2017-2022)

    • Figure China Angiotensin Receptor Blockers (ARBs) Consumption and Growth Rate (2017-2022)

    • Figure Japan Angiotensin Receptor Blockers (ARBs) Consumption and Growth Rate (2017-2022)

    • Figure India Angiotensin Receptor Blockers (ARBs) Consumption and Growth Rate (2017-2022)

    • Figure South Korea Angiotensin Receptor Blockers (ARBs) Consumption and Growth Rate (2017-2022)

    • Figure Global Angiotensin Receptor Blockers (ARBs) Consumption Forecast by Country (2022-2028)

    • Figure United States Angiotensin Receptor Blockers (ARBs) Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Angiotensin Receptor Blockers (ARBs) Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Angiotensin Receptor Blockers (ARBs) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Angiotensin Receptor Blockers (ARBs) Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Angiotensin Receptor Blockers (ARBs) Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Angiotensin Receptor Blockers (ARBs) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Valsartan Consumption and Growth Rate (2017-2022)

    • Figure Global Telmisartan Consumption and Growth Rate (2017-2022)

    • Figure Global Losartan Consumption and Growth Rate (2017-2022)

    • Figure Global Irbesartan Consumption and Growth Rate (2017-2022)

    • Figure Global Azilsartan Consumption and Growth Rate (2017-2022)

    • Figure Global Olmesartan Consumption and Growth Rate (2017-2022)

    • Figure Global Hypertension Consumption and Growth Rate (2017-2022)

    • Figure Global Cardiovascular Diseases Consumption and Growth Rate (2017-2022)

    • Figure Global Kidney Diseases Consumption and Growth Rate (2017-2022)

    • Figure Global Other Consumption and Growth Rate (2017-2022)

    • Figure Global Valsartan Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Telmisartan Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Losartan Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Irbesartan Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Azilsartan Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Olmesartan Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hypertension Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Cardiovascular Diseases Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Kidney Diseases Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Other Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Angiotensin Receptor Blockers (ARBs) Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Angiotensin Receptor Blockers (ARBs) Export by Region (Top 5 Countries) (2017-2028)

    • Table Bristol-Myers Squibb (Foundation Year, Company Profile and etc.)

    • Table Bristol-Myers Squibb Angiotensin Receptor Blockers (ARBs) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bristol-Myers Squibb Angiotensin Receptor Blockers (ARBs) Product and Service

    • Table Sanofi (Foundation Year, Company Profile and etc.)

    • Table Sanofi Angiotensin Receptor Blockers (ARBs) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sanofi Angiotensin Receptor Blockers (ARBs) Product and Service

    • Table Eli Lilly (Foundation Year, Company Profile and etc.)

    • Table Eli Lilly Angiotensin Receptor Blockers (ARBs) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Eli Lilly Angiotensin Receptor Blockers (ARBs) Product and Service

    • Table Pfizer (Foundation Year, Company Profile and etc.)

    • Table Pfizer Angiotensin Receptor Blockers (ARBs) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Angiotensin Receptor Blockers (ARBs) Product and Service

    • Table Merck (Foundation Year, Company Profile and etc.)

    • Table Merck Angiotensin Receptor Blockers (ARBs) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck Angiotensin Receptor Blockers (ARBs) Product and Service

    • Table Bayer (Foundation Year, Company Profile and etc.)

    • Table Bayer Angiotensin Receptor Blockers (ARBs) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bayer Angiotensin Receptor Blockers (ARBs) Product and Service

    • Table Jhonson and Johnson (Foundation Year, Company Profile and etc.)

    • Table Jhonson and Johnson Angiotensin Receptor Blockers (ARBs) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Jhonson and Johnson Angiotensin Receptor Blockers (ARBs) Product and Service

    • Table Astra Zeneca (Foundation Year, Company Profile and etc.)

    • Table Astra Zeneca Angiotensin Receptor Blockers (ARBs) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Astra Zeneca Angiotensin Receptor Blockers (ARBs) Product and Service

    • Table Novartis (Foundation Year, Company Profile and etc.)

    • Table Novartis Angiotensin Receptor Blockers (ARBs) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis Angiotensin Receptor Blockers (ARBs) Product and Service

    • Table GSK (Foundation Year, Company Profile and etc.)

    • Table GSK Angiotensin Receptor Blockers (ARBs) Sales, Price, Value and Gross Profit (2017-2022)

    • Table GSK Angiotensin Receptor Blockers (ARBs) Product and Service

    • Table Teva Pharmaceutical (Foundation Year, Company Profile and etc.)

    • Table Teva Pharmaceutical Angiotensin Receptor Blockers (ARBs) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Teva Pharmaceutical Angiotensin Receptor Blockers (ARBs) Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US